List view / Grid view

 

Episode 1 – Dr Sri Gopal, Janssen Pharmaceuticals

26 March 2021 | By

In this episode, DTR’s Assistant Editor, Hannah Balfour, discusses the development of treatments for schizophrenia with Dr Srihari Gopal, the Head of Psychiatry research and development for the Neuroscience Therapeutic Area at Janssen Pharmaceuticals. They also explore some of the most exciting developments in the field, Janssen’s schizophrenia R&D focus,…